Woodline Partners LP Pro Qr Therapeutics N.V. Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Woodline Partners LP holds 3,557,001 shares of PRQR stock, worth $8.61 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,557,001Holding current value
$8.61 Million% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding PRQR
# of Institutions
80Shares Held
40MCall Options Held
10.7KPut Options Held
24.1K-
Adage Capital Partners Gp, L.L.C. Boston, MA9.6MShares$23.2 Million0.05% of portfolio
-
Privium Fund Management B.V.4.99MShares$12.1 Million3.12% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.83MShares$6.84 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.83MShares$6.84 Million1.38% of portfolio
-
Ubs Group Ag2.31MShares$5.59 Million0.0% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $173M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...